Abstract
The peptide (PrP30-90), which was used in this study, was designed on the basis of amino acid sequence of the unstructured N-terminal domain of human prion protein. Flexibility of this moiety and physicochemical properties of PrP N-terminal domain are related to the ability of prion protein to bind metal cations and are probably linked with the pathological conformational changes and formation insoluble deposits of this protein in the brain, which were observed in transmissible spongiform encephalopathies (e.g. Creutzfeldt-Jakob disease, CJD) [1]. This peptide, as well as N-terminal domain of PrP, possesses octarepeat sequences containing four histidine residues which overlap with binding sites of metal ions (copper, zinc etc). Interactions with surfactants probably could influence secondary structure of N-terminal domain or even full human prion protein. The present study was aimed at determination of the effects of cationic gemini imidazolium surfactant and anionic surfactant with different spacer groups on secondary structure of human prion protein at different pH values. The studies were carried out in MES buffer (pH 5.5) and phosphate buffer (pH 7,4) using circular dichroism (CD, Fourier transform infrared spectroscopy (FTIR) spectroscopy, NMR diffusometry and transmission electron microscopy (TEM). This work was supported by the funds from the National Science Centre (Poland) granted on the basis of decision no. 2016/23/N/ST5/02013. [1] Cobb N.J., Surewicz W.K. (2009) Biochemistry. 48(12), 2574-2585.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.